SCHEMBL2199612

SCHEMBL2199612

Cc1nc(C(F)(F)F)c(C(=O)Nc2ccc(F)cc2-c2ccc(Cl)c(F)c2)s1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 3/20 0.44
WDR5 P61964 1/20 0.43
LMNA P02545 1/20 0.42
MAPT P10636 4/20 0.41
ALDH1A1 P00352 1/20 0.41
GAA P10253 2/20 0.41
THRB P10828 1/20 0.40
KDM4E B2RXH2 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 2/20 0.39
NTRK1 P04629 1/20 0.38
NTRK2 Q16620 1/20 0.38
ALOX15 P16050 1/20 0.38
ABL1 P00519 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM1 P11229 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12424051 0.94 WDR5 (0.41) CHRM3WDR5LMNAMAPTALDH1A1
SCHEMBL2202643 0.93 CHRM3 (0.44) CHRM3WDR5LMNAMAPTALDH1A1
SCHEMBL344007 0.89 MAPT (0.43) WDR5MAPTALDH1A1GAAKDM4E
SCHEMBL2200148 0.87 MAPT (0.49) WDR5LMNAMAPTALDH1A1GAA
SCHEMBL12424057 0.85 CHRM3 (0.44) CHRM3MAPTALDH1A1THRBKDM4E
SCHEMBL14564410 0.82 MAPT (0.44) LMNAMAPTALDH1A1GAAKDM4E
SCHEMBL5165138 0.82 CHRNA7 (0.47) CHRM3WDR5MAPTALDH1A1GAA
SCHEMBL557468 0.81 MAPT (0.45) CHRM3LMNAMAPTALDH1A1GAA
SCHEMBL12920787 0.80 MAPT (0.46) CHRM3WDR5MAPTALDH1A1GAA
SCHEMBL14564506 0.80 MAPT (0.43) LMNAMAPTALDH1A1GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977363-B2 Fungicides/bactericides for plant protection; exhibit a strong fortifying effect in plants; for controlling cereal diseases against Puccinia species, and diseases in viticulture and fruit and vegetable production against Botrytis, Venturia or Alternaria species; low toxicity; tolrerance BAYER CROPSCIENCE AG (DE) 2011-07-12 US disclosed
US-7977363-B2 Fungicides/bactericides for plant protection; exhibit a strong fortifying effect in plants; for controlling cereal diseases against Puccinia species, and diseases in viticulture and fruit and vegetable production against Botrytis, Venturia or Alternaria species; low toxicity; tolrerance BAYER CROPSCIENCE AG (DE) 2011-07-12 US disclosed
US-7977363-B2 Fungicides/bactericides for plant protection; exhibit a strong fortifying effect in plants; for controlling cereal diseases against Puccinia species, and diseases in viticulture and fruit and vegetable production against Botrytis, Venturia or Alternaria species; low toxicity; tolrerance BAYER CROPSCIENCE AG (DE) 2011-07-12 US disclosed
US-20080242708-A1 Biphenyl-Thiazolo-Carboxamides BAYER CROPSCIENCE AG (DE) 2008-10-02 US disclosed
US-20080242708-A1 Biphenyl-Thiazolo-Carboxamides BAYER CROPSCIENCE AG (DE) 2008-10-02 US disclosed
US-20080242708-A1 Biphenyl-Thiazolo-Carboxamides BAYER CROPSCIENCE AG (DE) 2008-10-02 US disclosed
EP-1786794-A2 BIPHENYL-THIAZOLO-CARBOXAMIDES Bayer CropScience Aktiengesellschaft (DE) 2007-05-23 EP disclosed
WO-2006024387-A2 BIPHENYL-THIAZOLO-CARBOXAMIDES BAYER CROPSCIENCE AG (DE) 2006-03-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242708-A1 Biphenyl-Thiazolo-Carboxamides MRPL21, CBR3, NAT1 CHRM3 1148/4885WDR5 1530/4885LMNA 3373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.